Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

23-Sep-21 - 21-Sep-22
Buy Ratio:29%


# Net Buyers:58
# Net Sellers:141

Previous 52 Weeks

24-Sep-20 - 22-Sep-21
Buy Ratio:28%
# Net Buyers:75
# Net Sellers:189
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Innoviva, Inc.($12.92K)$391.87M  
Mirati Therapeutics, Inc.($7.86M)$261.86M  
Eli Lilly & Co($335.40M)$257.05M  
Catalent, Inc.($417.58M)$181.66M  
Five Prime Therapeutics, Inc.--$170.46M  
New Net Buyers
CompanyNet Buy AmountChange
Incyte Corp$118.69M$134.56M  
Humanigen, Inc$3.00M$95.41M  
Precigen, Inc.$1.43M$46.08M  
Emergent Biosolutions Inc.$112.38K$26.57M  
Ionis Pharmaceuticals Inc$103.62K$24.69M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Kindred Biosciences, Inc.--($396.28M)  
Chemocentryx, Inc.($161.73M)($143.49M)  
Dicerna Pharmaceuticals Inc($132.05M)($96.81M)  
Merck & Co., Inc.($85.23M)($67.91M)  
Molecular Templates, Inc.$807.18K($51.80M)  
New Net Sellers
CompanyNet Buy AmountChange
Aravive, Inc.($10.45K)($21.07M)  
Alpine Immune Sciences, Inc.($66.28K)($9.30M)  
Intercept Pharmaceuticals, Inc.($154.61K)($5.55M)  
la Jolla Pharmaceutical Co($1.61M)($4.35M)  
Ardelyx, Inc.($3.79M)($4.05M)